
Pei Wang, PhD
About Me
Dr. Wang is a Professor of Genetics and Genomic Sciences. She received her Ph.D. in Statistics from Stanford University in 2004. Between 2004-2013, she served as a faculty in Fred Hutchinson Cancer Research Center and University of Washington, Seattle, WA. In Oct 2013, Dr. Wang joined the faculty of Icahn School of Medicine at Mount Sinai's Department of Genetics and Genomics. Dr. Wang’s research work has been focused on developing statistical and computational methods to address scientific questions based on data from high throughput biology/genetics experiments. Dr. Wang is a member of the Icahn Genomics Institute.
Language
English
Position
PROFESSOR | Genetics and Genomic Sciences
Education
BS, Peking University
PhD, Stanford University
Research
Publications
Selected Publications
- Natural language processing-based model to predict radiation pneumonitis in patients with locally advanced non-small cell lung cancer undergoing chemoradiotherapy: a retrospective cohort study. Julie R. Bloom, Nicole Tignor, Tielman Van Vleck, Dexter P. Mendoza, Sooyun Caroline Tavolacci, Olivia Fankuchen, Glen Chun, Stephanie Chang, Michael Chung, Stephanie Tuminello, Fred R. Hirsch, Abraham Chachoua, Joshua K. Sabari, Juan Wisnivesky, Ion Cotarla, Daniel Simmons, Kristin Hsieh, Chris Tackaberry, Kenneth E. Rosenzweig, Robert M. Samstein, Pei Wang, Rajwanth R. Veluswamy. eClinicalMedicine
- Integrated proteogenomic and metabolomic profiling of acute myeloid leukemias to identify molecular subtypes and associated therapy targets. Shih Chun A. Chu, Yi Hsiao, Chenwei Wang, Jennifer E. Kyle, Raghav Jain, Yamei Deng, Marina A. Gritsenko, Leanne E. Henry, Jonathan T. Lei, Yongchao Dou, Bahar Tercan, Zhiao Shi, Mahnoor N. Gondal, Chia Feng Tsai, John M. Elizarraras, Rosalie K. Chu, Fengchao Yu, Sunil K. Joshi, Xiaojun Jing, Daniel A. Polasky, Karl K. Weitz, Ginny Xiaohe Li, Vanessa L. Paurus, Chaevien S. Clendinen, Athena A. Schepmoes, Priscila M. Lalli, Josie G. Eder, Javier E. Flores, Kelly G. Stratton, James C. Pino, Camilo Posso, Vladislav A. Petyuk, Tyler J. Sagendorf, Yuanwei Xu, Omar M. Ibrahim, Ronald J. Moore, Rui Zhao, Jin Chen, Matthew E. Monroe, Mathangi Thiagarajan, Galen Hostetter, Chelsea Newton, Eunkyung An, Ana I. Robles, Xu Zhang, Nathan J. Edwards, Yin Lu, Pei Wang, Francesca Petralia, Avi Ma’ayan. Nature Cancer
- Integrative proteogenomic analysis provides molecular insights and clinical significance in gallbladder cancer. Zile Fu, Yuanli Song, Fen Liu, Lv Chen, Shangli Cai, Peng Cui, Guoqiang Wang, Wenchuan Xie, Shu Zhang, Li Ding, Pei Wang, Bing Zhang, Henry Rodriguez, Feiling Feng, Xufeng Zhang, Wei Gong, Qiang Gao, Daming Gao, Hu Zhou, Jia Fan. Cancer Cell
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Wang has not yet completed reporting of industry relationships or has no industry relationships to report.
Mount Sinai’s faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.